Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and ...

Equillium Inc (NASDAQ:EQ) stock plunged 12.4% following the company’s announcement that it will integrate cryptocurrency ...

Investing.com -- Equillium Inc (NASDAQ: EQ) stock tumbled 12.4% after the biotechnology company announced plans to integrate cryptocurrency into its treasury reserve strategy, a significant deviation ...

Shares of CommScope Holding Company, Inc. COMM +44.4% Get Free Report rose sharply in pre-market trading. The Wall Street Journal reported Sunday that Amphenol is nearing a deal for CommScope’s ...

DelveInsight's KIT Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

Find the latest Equillium, Inc. (EQ) stock quote, history, news and other vital information to help you with your stock trading and investing.

Equillium, Inc. (NASDAQ:EQ – Get Free Report) traded down 6.1% on Wednesday . The company traded as low as $0.37 and last traded at $0.38. 27,135 shares traded hands during trading, a decline of ...

LA JOLLA, Calif., May 01, 2025--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe ...

After losing some value lately, a hammer chart pattern has been formed for Equillium (EQ), indicating that the stock has found support. This, combined with an upward trend in earnings estimate ...

Equillium (EQ) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).